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Abstract

Shared decision making places an emphasis on patient understanding and engagement. However, when it comes to
treatment selection, research tends to focus on how doctors select pharmaceutical treatments. The current study is a
qualitative assessment of how patients choose among three common treatments that have varying degrees of scientific
support and side effects. We used qualitative data from 157 undergraduates (44 males, 113 females; mean age = 21.89
years) that was collected as part of a larger correlational study of depression and critical thinking skills. Qualitative
analysis revealed three major themes: shared versus independent decision making, confidence in the research and the
drug, and cost and availability. Some participants preferred to rely on informal networks such as consumer testimonials
while others expressed a false sense of security for over-the-counter treatments because they believe the drugs are
regulated. Many indicated that they avoid seeking mental health services because of the time and money needed. The
results indicate several factors influence selection of common depression treatments. Young adults indicate that when
reading prescription information, they most often rely on perceptions including ease of access, price, and beliefs about
drug regulations. General guidelines for treatment descriptions were created based on the qualitative analysis.
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Introduction
Over 60 million US residents search for health
information online to inform their medical decisions, with
more than 70% of them influenced by that information1.
Moreover, 1 in every 3 who accesses the internet for
health information will self-diagnose without ever seeing a
medical professional.1 As more people use the internet
each year to locate and self-diagnose health problems,2 it is
important to determine what information in treatment
descriptions is considered important and how that
information is interpreted by the consumers.
Online treatment descriptions vary widely based on the
type of webpage that is marketing the treatment
information.3 For example, a webpage dedicated to health
information will tend to provide general materials related
to maintaining a healthy lifestyle, or contain information
related to treating a specific condition.3 In many cases, the
information found online is inaccurate or incomplete, with
some studies noting over 75% of the webpages that
marketed health information were incorrect.3,4,5 Hansell
and colleagues2 determined that websites focused on
addressing mental health problems provided theoretically
biased information about the treatments available. Despite

the widespread misinformation, health-oriented websites
have been shown to facilitate help-seeking behaviors.3,2
Although research suggests that using health websites
increases help-seeking behaviors, little is known about how
the treatment information found on these websites affects
utilization and compliance to treatment schedules,
especially among young adults. More broadly speaking,
there is little research addressing young adults’ general
perspectives of treatment descriptions for mental health
pharmaceutical drugs.6 Thus, the primary purpose of the
current study is to determine what respondents perceive is
the most salient and important information presented
within mental health treatment descriptions and how that
influences their treatment selection. The results of this
research will help inform how to display medication
information to young adult consumers to encourage
utilization of efficacious mental health treatments when
needed.

Treatment Selection in the Health Decision Making
Process

There are numerous factors that influence a person’s
treatment selection in the health decision making process.
Jorm and colleagues7 suggest that the public often bases its
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opinions of treatments on general belief systems, which
are not typically supported by empirical research. For
example, some people believe that professional mental
health services are worse than getting no help for mental
issues.7 Others seek out informal networks of family and
friends for information regarding health choices.7 In these
cases, people are relying on the personal experience of
known individuals to aid their decision process instead of
deferring to a potential stranger (e.g., a doctor). Since these
referrals are generally rated more positively than referrals
from medical professionals,7 they can influence whether a
person utilizes empirically supported treatment versus a
pseudotreatment. It is thought that this reliance on an
informal network instead of medical professional’s opinion
could be part of the reason that fad treatments have seen a
rise in popularity and are a highly sought-after treatment
option.8
The acai berry is one such fad treatment, or
pseudotreatment, that is marketed for a variety of healthrelated issues, including mental health problems.9 The
popularity of this drug could be due to promotional
websites that includes information about how this berry is
used to treat a wide range of ailments including high blood
pressure and weight loss.9,10 Likewise, natural health stores
tend to carry acai berry supplements because of other
putative health benefits, such as reducing cancer risk,
improving depression symptoms, and increasing sexual
performance.11 While such information has broad appeal,
there is very little research to support these purported
health benefits.
These natural remedies are highly sought after, particularly
by young adults who are often consumers of alternative
medicines.12 How young adults choose among treatment
options is of particular interest because 18-25 years of age
is considered a critical time to develop healthy personal
care habits, including both physical and mental care.13
These young adults are not only at risk of suffering from
poor mental health, but are also at risk of developing poor
health decision making skills, which could have lifelong
implications.
To help young adults make better health decisions based
on information obtained online or through informal
networks, we sought to identify the components of
treatment information that are perceived as most salient
and influential. Determining how young adults view
treatment information can provide insight for modelling
future treatment descriptions increase young adults’
selection of efficacious mental health treatments over
pseudotreatments.

Method
This study was conducted at a mid-sized, urban state
university as part of a large mental health treatment
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selection survey that utilized mixed methodology. The
relationship between critical thinking skills and mental
health treatment selection was evaluated using quantitative
methods, which is reported elsewhere.14 Qualitative data
(reported in the current article) allowed the opportunity
for analyzing participants’ rationales for selecting one drug
description over two other drug descriptions. Table 1
includes the three treatment descriptions based on
Selective Serotonin Reuptake Inhibitors (SSRIs), St. Johns
Wort, or acai berries that were provided to each
participant. Each description was segmented into five
sentences and masked as Drug A, B, or C for a “general
mental health issue” to avoid any bias that could have
been introduced by providing the real drug name. The
order in which sentences were presented was randomized
for each participant.
Each sentence within the drug description was designed to
relate to one of five specific critical thinking domains. 14
The statements included structural keywords that were
used as the basis for the qualitative analysis discussed in
the current article. Participants were shown three
statements at a time, one from each drug description.
After selecting the statement, they preferred, participants
were asked to provide their rationale for the selection in an
open-ended comment box. This was repeated until all five
individual selections were made and comments were
provided.
After individual selections were finished, the complete
treatment descriptions were provided. The first full
description was shown to participants using masked
names, presented as Drug A, B, and C. To determine if
participants would change their selection based on name
recognition, the second full description included the actual
treatment names (SSRIs, St. Johns Wort, and acai berries).
Again, for each of these presentations, participants
selected which drug they preferred and provided their
rationale. The selection and comment process resulted in
seven distinct comments maximum per participant, which
range from no response provided to full paragraphs of
text. By asking for participants’ opinions on each of the
five statements, as well as the overall statements, we were
able to analyze what information was most salient during
the selection process.

Participants

In total, a random sample of 157 undergraduates from a
wide range of academic majors (44 males, 113 females)
ranging from 18- to 66-years-old (M = 21.89 years, median
= 19 years, SD = 7.382 years) were eligible and completed
all study requirements. The ethnic demographics were
diverse and representative of the overall student
population at the university: 64% of the sample indicated
they identified as White, 13% Black, 5% Hispanic, and
19% identified as some other ethnicity. Therefore, the
results could be generalizable to the student population
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Table 1. Treatment descriptions statements and structural keywords

from which they were drawn. These results may also
generalize to young adults in other collegiate settings based
on comparable demographics.

Ethical Considerations

The study was approved by a university ethics committee.
The informed consent emphasized voluntary participation
and maintenance of confidentiality. All participants signed
the informed consent via a digital signature prior to
completing the survey. They were also provided disclosure
information and signed a confidentiality agreement after
completing the survey.

Data Analysis

The qualitative data were analyzed using the grounded
theory method. This method requires marking key points
in the data through a series of codes, which were derived
directly from the empirical data.15 Researchers drew
deductive codes based on the treatment selection
statements provided to participants and then derived
additional 1-3 word phrases directly from the comments to
evaluate emerging patterns. The codes were grouped
thematically based on overlapping concepts and ideas.16

Patient Experience Journal, Volume 3, Issue 2 - Fall 2016

After coding and grouping was completed, the concepts
were analyzed to determine overarching categories and
themes for discussion.16

Results
Overview of Results

When structural keywords were removed for comment
analysis, three distinct themes were found that focused on
multiple aspects important to the participant’s treatment
selections in the health decision making process: Shared
versus Independent Decision Making, Confidence in the Research
and the Drug, and Cost and Availability. The major points
from each theme are summarized in Table 2 based on the
drug selected. In general, participants focused on 1-3
major themes throughout their individual responses, and
many of the themes crossed over the same topics. There
were overarching themes about safety and personal health,
which were differentially discussed in each of the three
treatment selection groups as part of the three major
themes.
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Table 2. Summary points of major themes

Shared versus Independent Decision Making in the
Treatment Selection Process

Respondents expressed personal feelings toward
prescriptions and doctors; specifically, if they prefer to rely
on their own research and experience or would rather have
recommendations from medical professionals. Those who
selected SSRIs indicated a preference for deferring to a
medical professional to make the treatment selection for
them, whereas those who selected St. John’s Wort or acai
berries preferred to have more control and autonomy in
the treatment selection process.
Participants who selected SSRIs indicated a general
reliance on advice from medical professionals and seemed
to defer to doctors’ expertise and judgment when making
medical treatment decisions. Many of these participants
indicated that they preferred SSRIs to the other two
options because it was available by “prescription only.” One
respondent went even further by stating that “all drugs
should be taken with the advice of a medical professional and not selfprescribed (even if over-the-counter)” with the exception of
painkillers and antihistamines. Another stated that if a
medical professional did not prescribe the drug, then there
would be no way of knowing how it could affect current
medication regimens.

on health. One person stated that “just because it's prescribed
doesn't mean it's the best for you, homeopathic is better.” This
statement suggested a preference for natural remedies,
which were perceived as safer than the pharmaceutical
option. However, these respondents also indicated a
consensus that some medical support is better than none at
all. Even with preferring natural treatment options, they
were hesitant to select a drug that does not have any
professional support. In addition to using natural remedies
that have some research support, these respondents
indicated a desire to avoid the “hassle” associated with
scheduling a doctor’s appointment and waiting to pick up
prescriptions. They trusted that St. John’s Wort is “the most
safe” and that over-the-counter accessibility is the most
“convenient” because it could reduce symptoms while
remaining easily accessible. One respondent stated:
By being an over-the-counter drug, it is much more
convenient to buy and use, compared to the process and
time it takes to see a doctor to get a prescription. The
drug is recommended by medical professionals which
supports the assumption that the drug is effective and
therefore, because of convenience and recommendation,
this one seems like the best choice.
Another respondent stated:

These responses suggest there was a need for
accountability and security that participants felt could only
be provided by medical professionals. The explicit
statement that professionals would be aware of any
possible drug interactions indicated that participants might
have felt that only medical professionals would know what
is detrimental to the patient. In general, those who selected
SSRIs expressed that physicians are a type of gatekeeper
for drugs that really work, which makes physicians more
reliable and trustworthy than an individual making his or
her own choice based on limited information. This sense
of trust in medical professionals seemed to comfort
participants who selected SSRIs and allowed them to
remove themselves from the treatment selection process.
Respondents who selected St. John’s Wort were also
concerned with the potentially negative impact drugs have
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Medication is not something I would purchase online,
and assuming the over the counter variety is just as
effective, I would prefer to get a medication without need
for a “medical professional.”
Even though those who selected acai berries also wanted
to avoid the hassle associated with scheduling
appointments and getting prescriptions filled, these
participants had a strong need to be “in control” of
themselves and their own treatment selection and health
decision making processes. Likewise, they preferred
natural remedies over pharmaceutical options. One
participant stated, “this treatment is the most natural which
means it is less harmful” than the other two treatment
options. Participants who preferred the acai berries did not
mention anything about the research supporting the drug,
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or lack thereof in this case. These respondents seemed to
focus more on starting with the simplest treatment option
first, and moving on to other options at a later time if
needed.

Confidence in Research and the Drug

In addition to the type of preferred decision making style
enacted for the treatment selection process, respondents
indicate they were interpreting the research and medication
regulation process as it related to the treatment
descriptions. This theme was particularly relevant to
participants who selected SSRIs because they often
focused on the scientific aspect of research that supported
the drug. Participants who selected St. John’s Wort and
acai berries were not differentiated in this theme as they
both commented on aspects that were not directly
influenced by the research supporting their drug of choice.
Those who chose St. John’s Wort or acai berries indicated
that scientific research should be more trustworthy than
consumer reviews, but generally prefer the consumer
reviews just the same. One participant states “even though I
shouldn’t trust consumer reviews, I’ve learned to trust them more than
“rigorous scientific research” at least from a consumer’s point of
view.” This commenter’s use of quotations around rigorous
scientific research suggests ambivalence, or possibly
disdain, toward the research process. The caveat expressed
concern that consumer reviews should be trusted less than
scientific research. However, the participant indicated one
cannot help but ignore gut instincts to rely on scientific
research because personal experience revealed consumer
testimonials were more reliable. This is alarming
considering that many homeopathic treatments rely on
informal consumer reviews to promote use.
Even with the general dismissal of scientific evidence,
respondents who selected St. John’s Wort or acai berries
indicate a belief that there is some form of regulatory body
overseeing these over-the-counter drugs and that they rely
on that regulation to ensure over-the-counter drugs are
safe. One respondent states “my limited understanding of the
[Federal Drug Administration (FDA)] indicates to me that drugs
available over the counter have been tested and approved for common
use.” This is a common misconception among people who
take over-the-counter drugs as opposed to prescriptions,
despite the warnings that many over-the-counter drugs,
such as health supplements and diet pills, are not
necessarily regulated by the FDA.
Respondents who chose the SSRI expressed much greater
appreciation for the research process than participants
who selected the other two drugs. One participant stated
that the SSRIs had “more positive information than others,” but
other commenters provided much more detail. One such
example stated that the SSRI option:
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. . . shows more scientific research that backs it up and
evidence. It has reported side effects, indicating it has
been thoroughly studied and surveys have been
conducted. The percentage of positive measurable
results is decent and significant, for there is a chance
of seeing a difference by taking this drug both
physiologically and mentally. It is also prescribed
under the care of a medical professional, meaning that
you yourself are being monitored, and under the care
and treatment of usually a doctor, which would make
me feel more safe in taking this drug, rather than
something OTC.
This respondent reflected on the benefits provided by the
scientific process. There was a general feeling of safety
knowing that the drug has been thoroughly vetted by
decades of research, and that it is regulated as a medication
available only through a prescription. These participants
discuss the need for considering the medical professional’s
opinion as well as the safety provided by professionals
monitoring drug use, in case there were any problems or
interactions with other current medications.

Cost and Availability

Many of the comments discussed the expenditure of time
and monetary resources, as well as how those costs
affected the respondents’ treatment selection. This theme
clearly differentiated the participants who chose SSRIs
from the participants who chose St. John’s Wort.
Interestingly, this theme was only briefly discussed by
participants who selected acai berries, mainly referencing
the aversion to spending time in doctor’s offices and
waiting for prescriptions. It is possible that these
respondents were not concerned with the monetary costs
associated with their drug selection, but further research
will be needed to determine the extent to which cost and
availability affect one’s selection of acai berries over St.
John’s Wort or SSRIs.
Participants who selected SSRIs focused primarily on how
the drug can be obtained only through prescription and
that it must recommended by medical professionals. These
respondents mentioned that the higher cost typically
associated with this drug would be acceptable because of
the benefits received by utilizing a medical professional for
treatment. One participant remarked that:
I chose the [SSRIs] overall because I would want
something that is in fact effective, even though it would
most likely cost more, I would also be monitored by
checking in with my medical professional, and be able
to discuss any side effects. The physician is more likely
to be more educated about this drug, especially if he or
she is prescribing it, for not only accountability
purposes, but medical ethics, so I would definitely go
with [SSRIs].

41

Young adult selection of mental health pharmaceuticals, Talboy et al.

The commenter is concerned with the multiple aspects of
the treatment, including the effectiveness, progression of
treatment, and knowledge of the medical professional.
This indicates that the participant was concerned with
future problems that could occur, such as the side effects,
and how to proactively prevent issues from occurring by
relying on a medical professional, even though this could
cost more in the short- and long-term.
Another participant who selected SSRIs chose this drug
because it is available by “prescription only and you would have
to see a doctor to get a script.” For respondents who provided
similar comments, there was a general consensus that
controlled access to the drug meant that the drug would
“probably work better” than a drug that is available over the
counter. This indicates a belief that pharmaceuticals are
more reliable than homeopathic treatments, which may
mentally offset the added cost of time and money needed
to acquire this treatment.
Participants who selected St. John’s Wort preferred
homeopathic treatments that were easily accessible, as
discussed in the other themes. These participants focused
on how the drug is available over-the-counter, which
meant it is probably had a “better price range” than drugs
available by prescription only. In addition to the time
needed to schedule and wait for appointments,
respondents focused on the cost of seeing a doctor which
could be used to try alternative treatments instead. These
respondents agreed that going to a doctor is “too expensive”
and if it was available over the counter without a
prescription while still being recommended, then it “will
usually be safe, non addicting, and maybe inexpensive.” One
commenter argued that:
[I] would choose a drug that is only available by
prescription if we currently had socialized medicine in
our country and visiting a doctor was low cost, but until
that kicks into full-effect, I'd opt for an over the counter
drug and skip the doctor visit altogether.
Several other responses indicated that this drug “is more
readily available” because it does not require a prescription
to purchase. Likewise, some respondents indicated that
having supporting research still influenced their selection,
but they preferred the supported drug that is available
without going to the doctor and is therefore easier to
access.

Discussion
The results provide insight into the treatment selection
process and what information may influence that process
from the young adults’ point of view. The majority of
these respondents were female and at an age when critical
medical decision making skills are being developed,13
allowing us to focus on elucidating what they felt was the
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most important and influential information within the
treatment descriptions. However, the breadth and depth of
the comments and emerging themes indicate that the
points raised have the potential to be important to all
young adults. Despite being given several key words such
as research and side effects, respondents provided detailed
information that went beyond these codes and applied
across overarching themes of safety and personal health,
both of which applicable to most young adults. The topics
(shared versus independent decision making, confidence in
research, and costs) that evolved from these descriptions
can be used to enhance online presentations of mental
health treatment descriptions that facilitate informed
health decision making among young adults.

Guidelines for Modeling Treatment Information

Based on the comments provided by participants, we
found three major areas of information within treatment
descriptions that are salient to young adults. Based on
analysis of these areas, we present general guidelines for
how that future treatment descriptions can be improved to
increase selection of efficacious treatments over
pseudotreatments. First, addressing the amount of
autonomy and self-directed assessment of available
treatments allowed in the treatment selection process may
increase utilization of empirical treatments. Second,
incorrect impressions about the research process and
overseeing regulatory agencies can be corrected through
clear labeling. Third, knowledge about the cost and
availability not only of the drug but also of the doctors and
their offices can be increased through targeted outreach
campaigns. Each is discussed in further detail below.

Information-seeking and autonomy in the treatment
selection process. Patient-centered care and shared

decision making is popular and desirable to many people,
but there is research suggesting some patients prefer a
more paternalistic approach to decision making (i.e.,
deferring to a medical professional).17 We noted this
pattern among individuals in the current study with regard
to the treatment selection process. Those who preferred
SSRIs aligned with a more paternalistic approach to
treatment selection, whereas those who preferred St.
John’s Wort or acai berries preferred more autonomy in
the treatment selection process. For example, participants
who selected SSRIs focused on the importance of having a
medical professional involved and controlling the decision
process because of safety concerns about the drug and
possible interactions. They also noted the presence of
supporting scientific research creates a sense of trust in the
drug and a pervasive belief that the drug will do what it
was created to do because it is regulated (i.e., only available
through a prescription despite increased costs).
Alternatively, those who selected St. John’s Wort or acai
berries preferred the ease of access and lower costs
associated with over-the-counter medications, which does
not necessitate direct involvement of a healthcare
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provider. These participants had preconceived notions
about the safety of using empirically supported treatments,
with many indicating a perception that homeopathic
treatments are safer.
Young adults who have preconceived notions about
available treatments (which could potentially be incorrect
or incomplete) may be educated through modification of
treatment descriptions and inclusion of information about
the wide range of treatment options available. For
example, it is important to convey to patients that there
are dozens of medications that fall under the broad
category of SSRIs.24 Additionally, there are the brand name
versions of the drugs as well as generic versions.24 Even
though these are all well-regulated treatments requires a
prescription, young adults may appreciate having the
choice to select among several empirically supported
treatments. Introducing choice into the treatment selection
process may provide a sense of autonomy, which in turn
may increase uptake of empirical treatments over
pseudotreatments. Increased feelings of autonomy can also
be achieved through provision of enhanced treatment
descriptions (either in an analog form such as a pamphlet
or digital form such as an information portal) describing
and comparing several different treatment options.
Enhanced treatment descriptions are beneficial for a
variety of reasons. For example, enhanced treatment
descriptions could acknowledge the different cost
structures of treatments (e.g., with or without insurance,
pharmaceutical discount programs), which would address
concerns related to pricing of the treatment. If information
is available on accessibility, this could be included in the
enhanced description as well. In addition to providing a
sense of control, enhanced treatment descriptions could
also be used to provide information about the efficacy of
each prescription, supporting (or contradicting) research
for the treatment, and relevant consumer testimonials.
Although testimonials are not traditionally provided in
prescription information sheets, many participants in the
current study indicated that they prefer this informal
review to scientific evidence. Therefore, including this
information for each empirically supported treatment may
increase selection of an efficacious treatment over a
pseudotreatment.

Research and regulatory agencies. Participants who

selected St. John’s Wort preferred to avoid the arduous
process of getting a prescription drug but still wanted the
benefit of supporting scientific research. However, these
participants noted the belief that over-the-counter drugs
are regulated by organizations such as the FDA, which
implies they believe these drugs are safe for consumption.
While St. John’s Wort supplements are regulated in
European countries such as Germany (where it is a highly
recommended over-the-counter treatment for depression
and anxiety), it is not regulated like prescriptions and over-
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the-counter medications in the US because it is classified
as an herb.18 Knowing that young adults may have a false
sense of security because they believe the drug is regulated
provides insight into what information should be
presented in treatment descriptions. Treatment
descriptions of all potential medications, including
pseudotreatments and supplements, should clearly indicate
if the drug is overseen by a regulatory agency.
Braun and colleagues19 suggests that pharmacists may be
the best point of entry for an oral discussion about
homeopathic drug safety, and thus regulatory oversight,
with young adults because aversion to doctors does not
appear to extend to pharmacists. In fact, people are more
likely to disclose all medication usage, including
unsubstantiated treatments like acai berries, to their
pharmacist as a means to avoiding unpleasant drug
interactions.19 This could create the opportunity for open
and frank discussions about the benefits of empirically
researched drugs over pseudotreatments. Likewise, this
could provide the opportunity to teach young adults about
the lack of oversight by regulatory agencies on over-thecounter treatments such as St. John’s Wort. These medical
professionals can proactively guide their patients by
providing appropriate, accurate, and complete medical
information regarding different treatment options.20,21

Addressing costs and availability. Many young adults

indicated that they wish to avoid the hassle and cost
associated with visiting the doctor, filling a prescription,
and complying with medical monitoring while receiving
treatment for mental health issues. However, young adults
might not realize the range of medical treatment options
that are available to them, especially college students who
have access to university resources.13 These university
resources include low or no-cost treatment options
available through the on-campus health and behavioral
health centers.13,22 Many campuses also offer counseling
services at no charge to students, which could alleviate
part of the concern mentioned by these participants.
Getting young adult students to these resources may be as
simple as advertising their availability. This could be
accomplished through concerted efforts by the university
health clinics. For example, emails sent out toward the
beginning of each semester when students enroll for
classes each year could include important information
about the health services available on campus. These
targeted emails may also benefit from including the
associated cost and benefit structure of utilizing campus
health resources. Additionally, posters may increase
exposure to information about the health clinics if they are
in highly visible areas with a lot of student traffic (such as
the dining hall).
For young adults who do not have access to university
health systems, there are other low-cost or free options
available in many communities. This includes community
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health clinics and clinics that offer services on a sliding
scale. Additionally, pharmaceutical treatments for mental
health disorders need not be full price for all individuals
who take them. For example, Walmart and Target offer
generic versions of some antidepressants for $4/month or
$10 for a three-month supply.24 There are also many
pharmaceutical companies that will provide deeply
discounted vouchers for patients who demonstrate a
financial need. Increasing access to this information may
help increase use of empirically-supported drugs over
pseudotreatments. Because many young adults seek out
health information online, the information portals could
potentially play a key role in presenting community-based
treatment centers and low or no-cost prescription
alternatives.

Future Directions
The results of the current study have indicated several
avenues for future research. In addition to the directions
discussed above, future research could also evaluate
differences between males and females in treatment
preferences and how those differences affect the treatment
selection process. The role of education in the treatment
selection process, and determining if the results are
generalizable to other populations such as older adults are
also potential areas of future research. Each point is briefly
addressed.
In the current study, our sample included a 2:1 female to
male ratio, which was representative of the student
population from which the sample was drawn but not the
overall young adult population. To determine if the
findings generalize well to a broad young adult population,
a follow-up study could be conducted with equivalent
sampling from each sex. Some research suggests that there
are few, if any, differences between males and females in
patient acceptance of treatment.25 However, others have
demonstrated differences between the sexes for utilization
of specific treatment options, such as surgery.26 Therefore,
an important next step will be determining if males and
females differentially weight certain treatment description
components during the treatment selection process.
Additionally, the study was conducted on a representative
sample of young adults from a university population,
which may not adequately represent all young adults.
Higher exposure to research terminology during collegiate
education may have cued our participants in to key terms
which may not be as salient in a sample with lower
education levels. However, our sample was a diverse group
of young adults who ran the spectrum of decision making
from the fully shared model to the paternalistic model.
Furthermore, they elaborated on key issues such as cost
and accessibility, which may be relevant to most young
adults. Therefore, these findings may be applicable to a
broader population. More research is needed to explore
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differences in treatment selection among young adults with
different levels of education.
Finally, preferences of young adults are often drastically
different from those of older adults on a wide range of
topics including autonomy and information-seeking
behaviors for medical decisions.27,28 The current study was
designed to assess what young adults perceive as the most
salient information within treatment descriptions. We
predicted that these findings would not be applicable to an
older adult population, and tested that prediction in a
follow up study not reported here. As expected, older
adults hold very different views about how to select
pharmacological treatments for mental health issues
(Talboy & Guttmann, unpublished manuscript).
Therefore, the results found here are relevant specifically
to a young adult population. Additional research is needed
to elucidate differences between how younger and older
adults approach the treatment selection process.

Summary
Several insights into how young adults interpret material
related to the selection of pharmaceutical treatments for
mental health issues were outlined with implications for
what should be addressed in mental health treatment
descriptions. These insights suggested several important
pieces of information to include in future treatment
descriptions. First, access to information about the wide
range of treatment options available is important for
informed decision making (including brand name and
generic alternatives). Second, enhanced treatment
descriptions for each drug, potential side effects, and
scientific support could include complementary reviews
from consumers and consumer advocates. These informal
reviews are preferred to scientific findings by many young
adults and aid treatment selection. Finally, increasing
general knowledge about available medical resources,
especially low-cost or no-cost doctor’s offices and
prescription drugs, may increase selection of empirical
treatments over pseudotreatments.
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